By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
LATEST POSTS
- 1
How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language - 2Online business Stages for Little Retailers
- 3IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- 4Doomed SpaceX Starlink satellite photographed from orbit
- 5Europe must reinvent warfare for ‘era of shocks,’ NATO’s Vandier says
- Chief of Staff Zamir warns IDF will collapse due to lack of manpower, raises 'ten red flags'
- DEA seizes 1.7 million counterfeit fentanyl pills in Colorado storage unit
- Cameroon says Russia has confirmed 16 Cameroonian soldiers died in Ukraine
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- Most loved Amusement Park Firecrackers Show: Which One Lights Up Your Evening?
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- Figure out How to Get the Best Open Record Rewards
- New research reveals urban raccoons across the US show early signs of domestication
- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
